This list is an analysis based on recent market events. It's not an investment recommendation.
About
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
The current price of RAMMF is $0.06 USD — it has increased by +0% in the past 24 hours. Watch RAMM Pharma stock price performance more closely on the chart.
What is RAMM Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange RAMM Pharma stocks are traded under the ticker RAMMF.
What is RAMM Pharma market cap?▼
Today RAMM Pharma has the market capitalization of 6.73M
What were RAMM Pharma earnings last quarter?▼
RAMMF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RAMM Pharma revenue for the last year?▼
RAMM Pharma revenue for the last year amounts to 3M USD.
What is RAMM Pharma net income for the last year?▼
RAMMF net income for the last year is -15.62M USD.